On the contrary, Wermann et al. reported an increased expression of the pluripotency markers NANOG and OCT3/4, or hypermethylation of distinct putative drivers of cisplatin-resistance, i.e., CFLAR, together with decreased cisplatin resistance upon 5-aza treatment in the seminoma cell line TCam-2 [11]. This evidence concerns the gene NANOG and seminoma.